{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:23:52Z","timestamp":1791861832159,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":7590,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1038\/modpathol.3880531","type":"journal-article","created":{"date-parts":[[2004,4,14]],"date-time":"2004-04-14T13:09:30Z","timestamp":1081948170000},"page":"365-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Markers of Proliferative Activity Are Predictors of Patient Outcome for Low-Grade Endometrioid Adenocarcinoma But Not Papillary Serous Carcinoma of Endometrium"],"prefix":"10.1016","volume":"15","author":[{"given":"Abdulmohsen","family":"Al Kushi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Aquino-Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.3880531_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199608293350907","article-title":"Endometrial carcinoma","volume":"335","author":"Rose","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.3880531_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-1-4757-3889-6_12","article-title":"Endometrial carcinoma","author":"Kurman","year":"1994","journal-title":"Blaustein's pathology of the female genital tract"},{"key":"10.1038\/modpathol.3880531_bib3","first-page":"228","article-title":"A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses","volume":"81","author":"Lax","year":"1997","journal-title":"Verh Dtsch Ges Pathol"},{"key":"10.1038\/modpathol.3880531_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2559.1998.00560.x","article-title":"Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium","volume":"33","author":"Burton","year":"1998","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.3880531_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/modpathol.3880051","article-title":"Theories of endometrial carcinogenesis: a multidisciplinary approach","volume":"13","author":"Sherman","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.3880531_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00004347-200010000-00003","article-title":"The molecular biology of endometrial tumorigenesis: does it have a message","volume":"19","author":"Ellenson","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.3880531_bib7","first-page":"277","article-title":"Pathology, hormonal aspects, and molecular genetics of the two types of emdometrial cancer","volume":"11","author":"Koshiyama","year":"1998","journal-title":"Cancer J"},{"key":"10.1038\/modpathol.3880531_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/gyno.1998.4956","article-title":"Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients","volume":"69","author":"Grice","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.3880531_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00000478-198203000-00002","article-title":"Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma","volume":"6","author":"Hendrickson","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.3880531_bib10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00000478-199206000-00008","article-title":"Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features","volume":"16","author":"Sherman","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.3880531_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/gyno.1994.1208","article-title":"Uterine papillary serous carcinoma: patterns of metastatic spread","volume":"54","author":"Goff","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.3880531_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/gyno.1995.9957","article-title":"Uterine papillary serous carcinoma: a clinicopathologic study of 30 cases","volume":"59","author":"Kato","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.3880531_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/gyno.1996.0120","article-title":"p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes","volume":"61","author":"Zheng","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.3880531_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ajcp\/102.5.665","article-title":"Immunohistochemical analysis of p53 in gynecologic tumors","volume":"102","author":"Inoue","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.3880531_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00001703-199602000-00012","article-title":"The significance of alterations in p53 expression in gynaecological neoplasms","volume":"8","author":"Manek","year":"1996","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1038\/modpathol.3880531_bib16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/bjc.1996.401","article-title":"Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma","volume":"74","author":"Soong","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.3880531_bib17","first-page":"177","article-title":"p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis","volume":"150","author":"Tashiro","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.3880531_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-2559.1999.00703.x","article-title":"p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma","volume":"35","author":"Burton","year":"1999","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.3880531_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/gyno.1999.5365","article-title":"Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators","volume":"73","author":"Lim","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.3880531_bib20","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0002-9378(96)70036-4","article-title":"p53 overexpression in advanced-stage endometrial adenocarcinoma","volume":"175","author":"Kohler","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1038\/modpathol.3880531_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/1097-0142(20010215)91:4<752::AID-CNCR1061>3.0.CO;2-E","article-title":"Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome","volume":"91","author":"Lim","year":"2001","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3880531_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ajcp\/96.4.444","article-title":"Ki-67 staining as a means to simplify analysis of tumor cell proliferation","volume":"96","author":"Hitchcock","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.3880531_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2559.1990.tb00788.x","article-title":"Monoclonal antibody Ki-67: its use in histopathology","volume":"17","author":"Brown","year":"1990","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.3880531_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/excr.2000.4888","article-title":"The Ki-67 protein: fascinating forms and an unknown function","volume":"257","author":"Endl","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1038\/modpathol.3880531_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1038\/modpathol.3880531_bib26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00004347-200007000-00002","article-title":"Simple hyperplasia of the endometrium: an evaluation of proliferative activity by Ki-67 immunostaining","volume":"19","author":"Ambros","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.3880531_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0046-8177(98)90197-6","article-title":"Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation","volume":"29","author":"Lax","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3880531_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0046-8177(98)80002-6","article-title":"Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression","volume":"29","author":"Lax","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3880531_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004347-199501000-00008","article-title":"Proliferative and apoptotic status in endometrial adenocarcinoma","volume":"14","author":"Kuwashima","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.3880531_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00004347-200101000-00006","article-title":"Immunohistochemical analysis of gynecologic tumors","volume":"20","author":"Yaziji","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.3880531_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2184.1994.tb01421.x","article-title":"The proliferation-associated Ki-67 protein: definition in molecular terms","volume":"27","author":"Duchrow","year":"1994","journal-title":"Cell Prolif"},{"key":"10.1038\/modpathol.3880531_bib32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/BF02388205","article-title":"Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications","volume":"25","author":"Yu","year":"1993","journal-title":"Histochem J"},{"key":"10.1038\/modpathol.3880531_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/10520299709082216","article-title":"Cell proliferation indexes: a biomarker in solid tumors","volume":"72","author":"Elias","year":"1997","journal-title":"Biotech Histochem"},{"key":"10.1038\/modpathol.3880531_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00004347-199607000-00003","article-title":"Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity","volume":"15","author":"Yamauchi","year":"1996","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.3880531_bib35","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1200\/JCO.1999.17.5.1382","article-title":"Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study","volume":"17","author":"Salvesen","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.3880531_bib36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1006\/gyno.1999.5615","article-title":"MIB-1 in endometrial carcinoma: prognostic significance with 5-year follow-up","volume":"75","author":"Geisler","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.3880531_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/gyno.1996.0159","article-title":"Proliferation index determined by MIB-1 and recurrence in endometrial cancer","volume":"61","author":"Geisler","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.3880531_bib38","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<1942::AID-CNCR15>3.0.CO;2-Y","article-title":"A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction","volume":"78","author":"Nordstrom","year":"1996","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3880531_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-200001000-00003","article-title":"Histopathologic grading of ovarian carcinoma: a review and proposal","volume":"19","author":"Silverberg","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.3880531_bib40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00004347-200010000-00009","article-title":"Grading of ovarian carcinomas","volume":"19","author":"Mayr","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.3880531_bib41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0090-8258(92)90228-B","article-title":"Diagnostic and prognostic significance of the mitotic index in endometrial adenocarcinoma","volume":"46","author":"Pirog","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.3880531_bib42","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/1097-0142(19920815)70:4<790::AID-CNCR2820700413>3.0.CO;2-8","article-title":"Aggressive stage I grade 1 endometrial carcinoma","volume":"70","author":"Tornos","year":"1992","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3880531_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0090-8258(89)90027-9","article-title":"Announcements: FIGO stages\u20141988 revision","volume":"35","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.3880531_bib44","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0046-8177(98)90429-4","article-title":"Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium","volume":"29","author":"Ioffe","year":"1998","journal-title":"Hum Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3880531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3880531","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222044659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222044659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3880531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:19:38Z","timestamp":1760231978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222044659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0893395222044659"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.3880531","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of Proliferative Activity Are Predictors of Patient Outcome for Low-Grade Endometrioid Adenocarcinoma But Not Papillary Serous Carcinoma of Endometrium","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.3880531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}